Q4 2022 Holdings
Filed 2023-02-14 | 19 holdings | $237.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Amryt Pharma PLC - Spnr ADR | SPONSORED ADS | 03217L106 | $46.2M | 6,333,239 | 19.4% |
| Apollo Endosurgery Inc(HQ8F) | COM | 03767D108 | $37.2M | 3,726,584 | 15.6% |
| CTI Biopharma Corp(CTIC1USD) | COM | 12648L601 | $29.7M | 4,934,100 | 12.5% |
| Adma Biologics Inc(ADMA) | COM | 000899104 | $26.9M | 6,940,000 | 11.3% |
| Quidelortho Corp(QDEL) | COM | 219798105 | $25.7M | 300,000 | 10.8% |
| Xeris Biopharma Holdings Inc(XERS) | COM | 98422E103 | $14.9M | 11,195,189 | 6.3% |
| Urogen Pharma LTD(URGN) | COM | M96088105 | $11.6M | 1,304,947 | 4.9% |
| Third Harmonic BIO Inc(THRD) | COM | 88427A107 | $8.7M | 2,015,301 | 3.6% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $8.6M | 194,836 | 3.6% |
| Evolus Inc(EOLS) | COM | 30052C107 | $6.3M | 834,432 | 2.6% |
| Rezolute Inc(RZLT) | COM NEW | 76200L309 | $6.3M | 3,021,504 | 2.6% |
| Castle Biosciences Inc(CSTL) | COM | 14843C105 | $4.2M | 178,240 | 1.8% |
| Conformis Inc(CFMS) | COM | 20717E101 | $2.5M | 748,194 | 1.0% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $2.1M | 108,769 | 0.9% |
| Exagen Inc(XGN) | COM | 30068X103 | $2.0M | 854,042 | 0.9% |
| Maxcyte Inc(MXCT) | COM | 57777K106 | $1.5M | 273,287 | 0.6% |
| Omniab Inc(OABI) | COM | 68218J103 | $1.3M | 354,266 | 0.5% |
| Xoma Corp(XOMA) | COM NEW | 98419J206 | $1.2M | 64,459 | 0.5% |
| Optinose Inc | COM | 68404V100 | $940.3K | 508,284 | 0.4% |